Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04444518
Other study ID # STUDY00005115
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date November 11, 2020
Est. completion date June 30, 2024

Study information

Verified date August 2023
Source University of Rochester
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pregnant women who get influenza are more likely than non-pregnant women to have serious complications, including hospitalizations, death, preterm labor and premature birth. Pertussis can cause hospitalization or death for newborns. However, influenza and Tdap vaccination rates for pregnant women are low nationally. In this study, the investigators will perform a randomized controlled trial aimed at practice change in obstetricians' offices, with an overall goal of reducing morbidity and mortality from influenza and pertussis infections.


Description:

Infants under 6 months of age at increased risk of both influenza (flu) and pertussis disease, and pregnant women risk serious illness and premature labor from flu. The Advisory Committee on Immunization Practices recommends that women receive a flu vaccine in flu season, and tetanus toxoid, reduced diphtheria toxoid, acellular pertussis (Tdap) vaccine during each pregnancy (ideally between 27-36 weeks) to lower the risk for flu and pertussis disease for themselves and their infants. However, only half of pregnant women in the US receive a flu and Tdap vaccine, respectively; only 33% of women receive both vaccines. Lack of vaccination stems from a combination of patient (lack of knowledge, vaccine hesitancy), provider (suboptimal communication skills, missed opportunities), and system (e.g. lack of standing orders and patient reminders) factors. An effective intervention is needed to improve flu and Tdap vaccination rates for pregnant women. To address these low vaccination rates the investigators plan to use a clustered RCT (randomizing practices), allocating half of the participating practice sites within each health system to the VAX-MOM intervention and the other half to standard of care. The multi-component VAX-MOM intervention will be comprised of: training in communication, provider prompts, standing orders, and feedback on vaccination rates.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 9903
Est. completion date June 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: Patients - Sex is female - Pregnant - identified as being eligible for influenza or Tdap vaccine Providers - any provider, nurse or staff associated with the participating sites Exclusion Criteria: Patients - none Providers - none

Study Design


Intervention

Behavioral:
VAX-MOM Intervention
The multi-component VAX-MOM intervention will be comprised of: training in communication, provider prompts, standing orders, and feedback on vaccination rates.
Standard of Care
Standard vaccine education and processes provided to patients by obstetric practices.

Locations

Country Name City State
United States Unity OBGYN at Brockport Brockport New York
United States Clifton Springs Hospital & Clinic Clifton Springs New York
United States El Monte Comprehensive Health Center El Monte California
United States Finger Lakes Medical Associates OBGYN-Geneva Geneva New York
United States RRH OBGYN at Henrietta Henrietta New York
United States High Desert Regional Health Center Lancaster California
United States Hubert Humphrey Comprehensive Health Center Los Angeles California
United States Hudson Comprehensive Health Center Los Angeles California
United States Los Angeles County USC Medical Center Los Angeles California
United States MLK Outpatient Center Los Angeles California
United States Ronald Reagan OB Los Angeles California
United States UCLA Faculty Practice. OBGYN at West Medical Los Angeles California
United States The Women's Center at Newark Newark New York
United States Finger Lakes Medical Associates OBGYN-Penn Yan Penn Yan New York
United States Community OB Rochester New York
United States Highland Women's Health Rochester New York
United States Strong Perinatal Associates Rochester New York
United States The Women's Center at Alexander Park Rochester New York
United States The Women's Center at Clinton Rochester New York
United States The Women's Center at RGH Rochester New York
United States Unity OBGYN at Clinton Crossings Rochester New York
United States Unity OBGYN at Park Ridge Rochester New York
United States Unity OBGYN at Parkway Rochester New York
United States Unity OBGYN at Ridgeway Rochester New York
United States Unity OBGYN at West Main Rochester New York
United States University OB/GYN Rochester New York
United States UR/HH Midwifery Rochester New York
United States Women's Health Practice at Lattimore Rochester New York
United States Santa Monica Faculty Practice Santa Monica California
United States UCLA OBGYN Nurse-Midwives Clinic Santa Monica California
United States Olive View Sylmar California
United States Harbor UCLA Torrance California
United States South Bay (Torrance) Torrance California
United States Santa Clarita OBGYN Valencia California
United States The Women's Center at Victor Victor New York
United States Bay Creek Midwifery Webster New York
United States West Lake/Thousand Oaks Westlake Village California

Sponsors (3)

Lead Sponsor Collaborator
University of Rochester Centers for Disease Control and Prevention, University of California, Los Angeles

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in the rate of influenza vaccination Average rate of vaccination over 6 months during baseline will be compared with average rate of vaccination over 6 months during intervention, for vaccine eligible patients at participating OB/GYN practice sites. Vaccination status will be obtained from patient electronic health records. 6 months during the 2019-2020 flu season (baseline), compared to 6 months during the 2021-2022 flu season (intervention)
Primary Change in the rate of Tdap vaccination Average rate of vaccination over 12 months during baseline will be compared with average rate of vaccination over 12 months during intervention, for vaccine eligible patients at participating OB/GYN practice sites. Vaccination status will be obtained from patient electronic health records. 12 month baseline compared to 12 month intervention
Secondary Number of patients seen in the practices 12 months during intervention period
Secondary Number of providers/nurses/staff completing training modules 12 months during intervention period
Secondary Flu and Tdap vaccination rates by insurance group (public vs private) 12 months during intervention period
See also
  Status Clinical Trial Phase
Completed NCT05017974 - Research on Improving Sleep During Pregnancy N/A
Completed NCT03284515 - Vaccination In Pregnancy Gene Signature: VIP Signature Study
Recruiting NCT05969795 - Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support Phase 1
Recruiting NCT06051201 - Innovation for Small-scale Experiments: ReceptIVFity Test N/A
Recruiting NCT04828382 - Prospective Study of Pregnancy in Women With Cystic Fibrosis
Enrolling by invitation NCT04527926 - STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy N/A
Recruiting NCT04278651 - Early Antenatal Support for Iron Deficiency Anemia Phase 4
Recruiting NCT04405700 - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Recruiting NCT06258902 - Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
Completed NCT05487196 - Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia Phase 2
Completed NCT03750968 - Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects Phase 2
Enrolling by invitation NCT06127277 - Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care N/A
Completed NCT05897697 - Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
Recruiting NCT05899101 - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Completed NCT04296396 - Opioid Prescription After Cesarean Trial Phase 3
Not yet recruiting NCT06069856 - Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06069869 - Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Not yet recruiting NCT06079918 - Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania Phase 3